Welcome to our dedicated page for JYAC news (Ticker: JYAC), a resource for investors and traders seeking the latest updates and insights on JYAC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JYAC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JYAC's position in the market.
On August 23, 2022, Jiya Acquisition Corp. (NASDAQ: JYAC) received notification from NASDAQ regarding non-compliance with Listing Rule 5250(c)(1) due to the absence of its Quarterly Report on Form 10-Q for the period ended June 30, 2022. The Company submitted the report on August 31, 2022 and, on September 1, 2022, NASDAQ confirmed that Jiya is no longer required to submit a compliance plan. This notification does not immediately affect the Company's NASDAQ listing.
FAQ
What is the market cap of JYAC (JYAC)?
